TherapeuticsMD (TXMD) Prices $110M Share Common Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/31/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- KBR names its Mission Technology Solutions spinoff Trinzic
- Wall Street ends sharply higher, lifted by soaring Microsoft
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
After-Hours Stock Movers 02/10: (MVIS) (DMTK) (RNWK) Higher; (FLDM) (ELY) (KDMN) Lower (more...)
February 10, 2021 5:54 PM ESTToday's After-Hours Stock Movers:
MicroVision, Inc. (NASDAQ: MVIS) 38.5% HIGHER; announced that it has received necessary components and equipment to meet its April milestone of completing A-Samples of its Long Range Lidar Sensor. The Company also announced that it has started outdoor testing of key performance features on its development platform.
DermTech, Inc. (NASDAQ: DMTK) 22.7% HIGHER; has contracted, effective 2/1/2021, with Blue Cross Blue Shield of Texas (BCBSTX) to make DermTechs Pigmented Lesion Assay (PLA) available to its approximately 6... More
TherapeuticsMD (TXMD) Announces Underwritten Public Offering of its Common Stock
February 10, 2021 4:02 PM ESTTherapeuticsMD, Inc. (NASDAQ: TXMD) today announced an underwritten public offering of its common stock. The Company has granted the underwriter a 30-day option to purchase up to an additional 15% of the number of shares of its common stock offered in the offering. All of the... More
